Dirk Landgraf
InvestorPrincipal at Dementia Discovery · Principal at SV Health Investors
Boston, Massachusetts
Writes $1M – $10M checks · typically $5M
Find your path to Dirk
408 people in our graph share verified history with Dirk — schools, employers, funds. One of them is your warm intro.
Noubar AfeyanunlockedDirk: together at Evelo Biosciences (2015)
Dirk: together at Harvard Business School Online
×6Dirk: together at Harvard Medical School
Dirk: together at Nitrase Therapeutics
About
Dirk Landgraf joined SV Health Investors in 2020 and is a Principal on the Dementia Discovery Fund (DDF) team, where he helps form and fund companies developing new medicines for dementia and supports DDF portfolio companies with due diligence and strategic, business development, and operational needs. Before SV, he was an Associate Director in the External Innovation group at Biogen in Cambridge, MA, evaluating business development opportunities across neurological therapeutic areas, and earlier was a Postdoctoral Fellow in Susan Lindquist's lab at the Whitehead Institute at MIT. He holds a PhD from Harvard University's Department of Systems Biology at Harvard Medical School and BSc and MSc degrees in Biochemistry from the Technical University of Munich.
Invests in
Biotech
Experience
- SV Health InvestorsPrincipalcurrent2020 — present
- Dementia Discovery Fund (DDF)Principalcurrent2023 — presentBoston, Massachusetts, United States
- Dementia Discovery Fund (DDF)Vice President2021 — 2023Boston, Massachusetts, United States
- Dementia Discovery Fund (DDF)Senior Associate2020 — 2021Boston, Massachusetts, United States
- Montara Therapeutics, Inc.Member Board of Directorscurrent2024 — presentSan Francisco Bay Area
- Harness TherapeuticsBoard Observercurrent2023 — presentUnited Kingdom
- Nitrase TherapeuticsBoard Observercurrent2025 — present
- TranSINE TherapeuticsBoard Observer2020 — 2023United Kingdom
- Tiaki TherapeuticsMember Board of Directors2021 — 2022Cambridge, Massachusetts, United States
- BiogenAssociate Director, External Innovation and New Indications2019 — 2020
- BiogenSenior Manager, External Innovation and New Indications2019
- BiogenSenior Manager, External Portfolio Innovation Unit2019Greater Boston Area
- BiogenManager, External Portfolio Innovation Unit2018 — 2019
- BiogenManager, Business Development and External Innovation2016 — 2018
- Whitehead Institute for Biomedical Research - MITPostdoctoral Fellow2013 — 2016Cambridge, Massachusetts, United States
- Evelo BiosciencesIP/Biotech Part-time Consultant2015Cambridge, MA
- Harvard Medical SchoolResearch Scientist / Postdoctoral Fellow2012Laboratory of Johan Paulsson
- Harvard Medical SchoolPhD Student in the Harvard Systems Biology Program2006 — 2012Department of Systems Biology, Laboratory of Johan Paulsson
- Harvard UniversityTeaching Fellow2008Cambridge, MA, USA
- Dana-Farber Cancer InstituteVisiting Scientist at Dana-Farber Cancer Institute2005 — 2006Laboratory of Pam Silver
- Harvard Medical SchoolResearch Trainee2004Department of Microbiology & Molecular Genetics, Laboratory of Dr. Jon Beckwith
- McGill UniversityResearch Trainee2003Department of Biochemistry, NMR lab, Prof. Dr. Kalle Gehring
- German Red CrossEmergency Medical Technician (EMT)1999 — 2000Germany
Skills & more
Matlab2PythonMATLABMolecular Biology27Cell Biology22Microscopy20Biochemistry13Fluorescence Microscopy12Cell Culture8Genetics7Protein Expression6Molecular Cloning6
+12 more
Western BlottingGenomicsPCRProtein PurificationBiotechnologyMicrobiologyLife SciencesIntellectual PropertyNeuroscienceStatisticsData AnalysisEntrepreneurshipLanguages English · German
From Dirk's professional profile.
Colleagues at Dementia Discovery
Catherine Bingham
General Partner at Dementia Discovery
Christian Jung
Partner at Dementia Discovery
Damian Crowther
ex-AstraZeneca at PICUS CAPITAL
Dirk Landgraf
Principal at Dementia Discovery
Georgia Frost
Senior Associate at Dementia Discovery
Hamish Cameron
General Partner at Dementia Discovery
Huiyuan Zhang
Senior Associate at Dementia Discovery
James Costine
General Partner at Dementia Discovery
Network4
Alex Badamchi-Zadeh
Vice President at SV Health Investors
Charles Dunn
Principal at SV Health Investors
Christian Jung
Partner at Dementia Discovery
Darren Black
Partner at SV Health Investors
Investors connected to Dirk in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Dirk Landgraf?
- Dirk Landgraf joined SV Health Investors in 2020 and is a Principal on the Dementia Discovery Fund (DDF) team, where he helps form and fund companies developing new medicines for dementia and supports DDF portfolio companies with due diligence and strategic, business development, and operational needs. Before SV, he was an Associate Director in the External Innovation group at Biogen in Cambridge, MA, evaluating business development opportunities across neurological therapeutic areas, and earlier was a Postdoctoral Fellow in Susan Lindquist's lab at the Whitehead Institute at MIT. He holds a PhD from Harvard University's Department of Systems Biology at Harvard Medical School and BSc and MSc degrees in Biochemistry from the Technical University of Munich.
- Where does Dirk Landgraf work?
- Dirk Landgraf is Principal at Dementia Discovery.
- What does Dirk Landgraf invest in?
- Dirk Landgraf invests in Biotech.
- What check size does Dirk Landgraf write?
- Dirk Landgraf typically writes checks of $1M – $10M.
- Where did Dirk Landgraf go to school?
- Dirk Landgraf studied at Harvard University (Doctor of Philosophy (PhD), Systems Biology); Technical University of Munich (Master of Science (MSc), Biochemistry); Technical University of Munich (Bachelor of Science (BSc), Biochemistry).
Same school
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Also attended Technical University of Munich423
Daan BoekhoudtInvestment Analyst at Cottonwood Technology FundJulian von EckartsbergManaging Director Europe at Burda Principal InvestmentsLuisa DüsbergPrincipal at Burda Principal InvestmentsHannes Voucko-GlocknerInvestment Analyst at Burda Principal InvestmentsPaula SchultheissSenior Associate at AN Venture PartnersThomas MeierPartner, Head of Resilience in Energy & Resources Investments at Verve Ventures
+ 417 more
Also attended Harvard Business School Online245
MariaInvestor at InvestinorKelsey BeausoleilBusiness Development Network at Redpoint VenturesOliver MarquesPartner, Capital Formation at March Capital PartnersJohn DemeterInvestor at Khosla VenturesJeff RoseAdvisor at AI CapitalRobAdvisor at TFX Capital
+ 239 more
Shared employers
Also worked at Dementia Discovery Fund (DDF)5
Also worked at Biogen42
Jigar RaythathaInvestor at Third Rock VenturesRichard RansohoffVenture Partner at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesRoy LobbVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityJohn McCabePortfolio Company CFO & COO at Longwood Fund
+ 36 more
Also worked at Whitehead Institute for Biomedical Research - MIT12
Satish JindalGeneral Partner at Advent Life SciencesStella PaffenholzSenior Associate at Atlas VentureBeccaInvestor at Sanofi VenturesJakob LovenPartner at Nextech InvestMichael LamprechtInvestment Manager at TenmileBrett ChevalierVenture Partner at Anterra Capital
+ 6 more
Also worked at Harvard Medical School274
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux CapitalZach CollinsPartner at Mission BiocapitalAlexi Nazem, MDGeneral Partner at AlleyCorp
+ 268 more